US Stock MarketDetailed Quotes

MRSN Mersana Therapeutics

Watchlist
  • 2.100
  • -0.010-0.47%
Close Oct 18 16:00 ET
  • 2.100
  • 0.0000.00%
Post 20:02 ET
257.62MMarket Cap-2470P/E (TTM)

Mersana Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
Total revenue
-78.48%2.29M
18.50%9.25M
38.65%36.86M
-27.14%10.7M
38.13%7.7M
148.69%10.65M
283.20%7.8M
61,716.28%26.58M
133,427.27%14.69M
50,563.64%5.57M
Operating revenue
-78.48%2.29M
18.50%9.25M
38.65%36.86M
-27.14%10.7M
38.13%7.7M
148.69%10.65M
283.20%7.8M
61,716.28%26.58M
133,427.27%14.69M
50,563.64%5.57M
Cost of revenue
Gross profit
Operating expense
-58.68%27.75M
-53.90%30.25M
-9.78%207.81M
-47.73%31.63M
-33.41%43.43M
19.85%67.16M
35.02%65.6M
36.38%230.35M
25.96%60.51M
43.64%65.21M
Selling and administrative expenses
-42.25%10.5M
-36.93%11.56M
4.53%59.54M
-31.55%10.13M
-11.52%12.89M
22.86%18.19M
43.39%18.33M
54.42%56.96M
38.70%14.81M
43.95%14.57M
-General and administrative expense
-42.25%10.5M
-36.93%11.56M
4.53%59.54M
-31.55%10.13M
-11.52%12.89M
22.86%18.19M
43.39%18.33M
54.42%56.96M
38.70%14.81M
43.95%14.57M
Research and development costs
-64.78%17.25M
-60.47%18.69M
-14.49%148.27M
-52.97%21.5M
-39.71%30.53M
18.77%48.97M
32.03%47.28M
31.34%173.39M
22.32%45.71M
43.55%50.64M
Operating profit
54.95%-25.46M
63.67%-21M
16.10%-170.96M
54.33%-20.93M
40.09%-35.73M
-9.18%-56.5M
-24.16%-57.8M
-20.67%-203.77M
4.59%-45.83M
-31.40%-59.64M
Net non-operating interest income expense
-45.90%1.19M
3.48%1.7M
1,897.75%8M
108.76%1.88M
1,428.49%2.29M
567.80%2.19M
332.01%1.64M
62.98%-445K
194.75%902K
-107.23%-172K
Non-operating interest income
-32.59%2.17M
2.90%2.7M
318.77%12.07M
57.07%2.93M
366.38%3.3M
1,006.19%3.22M
14,461.11%2.62M
4,335.38%2.88M
6,334.48%1.87M
4,620.00%708K
Non-operating interest expense
-4.10%983K
1.93%1M
22.39%4.07M
8.71%1.05M
15.57%1.02M
34.87%1.03M
35.77%983K
162.67%3.33M
-1.73%964K
797.96%880K
Other net income (expense)
-8.71M
-499K
-8.21M
Special income (charges)
----
----
---8.71M
---499K
---8.21M
----
----
--0
--0
--0
-Less：Restructuring and merger&acquisition
----
----
--8.71M
--499K
--8.21M
----
----
--0
--0
--0
Income before tax
55.31%-24.27M
65.63%-19.31M
15.94%-171.67M
56.50%-19.54M
30.35%-41.66M
-4.00%-54.31M
-18.84%-56.16M
-20.08%-204.21M
8.29%-44.92M
-31.54%-59.81M
Income tax
Net income
55.31%-24.27M
65.63%-19.31M
15.94%-171.67M
56.50%-19.54M
30.35%-41.66M
-4.00%-54.31M
-18.84%-56.16M
-20.08%-204.21M
8.29%-44.92M
-31.54%-59.81M
Net income continuous Operations
55.31%-24.27M
65.63%-19.31M
15.94%-171.67M
56.50%-19.54M
30.35%-41.66M
-4.00%-54.31M
-18.84%-56.16M
-20.08%-204.21M
8.29%-44.92M
-31.54%-59.81M
Minority interest income
Net income attributable to the parent company
55.31%-24.27M
65.63%-19.31M
15.94%-171.67M
56.50%-19.54M
30.35%-41.66M
-4.00%-54.31M
-18.84%-56.16M
-20.08%-204.21M
8.29%-44.92M
-31.54%-59.81M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
55.31%-24.27M
65.63%-19.31M
15.94%-171.67M
56.50%-19.54M
30.35%-41.66M
-4.00%-54.31M
-18.84%-56.16M
-20.08%-204.21M
8.29%-44.92M
-31.54%-59.81M
Basic earnings per share
57.45%-0.2
69.23%-0.16
32.11%-1.48
63.64%-0.16
42.62%-0.35
14.55%-0.47
11.86%-0.52
9.54%-2.18
35.29%-0.44
3.17%-0.61
Diluted earnings per share
57.45%-0.2
69.23%-0.16
32.11%-1.48
63.64%-0.16
42.62%-0.35
14.55%-0.47
11.86%-0.52
9.54%-2.18
35.29%-0.44
3.17%-0.61
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
Unqualified Opinion
--
--
--
--
--
--
--
(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022
Total revenue -78.48%2.29M18.50%9.25M38.65%36.86M-27.14%10.7M38.13%7.7M148.69%10.65M283.20%7.8M61,716.28%26.58M133,427.27%14.69M50,563.64%5.57M
Operating revenue -78.48%2.29M18.50%9.25M38.65%36.86M-27.14%10.7M38.13%7.7M148.69%10.65M283.20%7.8M61,716.28%26.58M133,427.27%14.69M50,563.64%5.57M
Cost of revenue
Gross profit
Operating expense -58.68%27.75M-53.90%30.25M-9.78%207.81M-47.73%31.63M-33.41%43.43M19.85%67.16M35.02%65.6M36.38%230.35M25.96%60.51M43.64%65.21M
Selling and administrative expenses -42.25%10.5M-36.93%11.56M4.53%59.54M-31.55%10.13M-11.52%12.89M22.86%18.19M43.39%18.33M54.42%56.96M38.70%14.81M43.95%14.57M
-General and administrative expense -42.25%10.5M-36.93%11.56M4.53%59.54M-31.55%10.13M-11.52%12.89M22.86%18.19M43.39%18.33M54.42%56.96M38.70%14.81M43.95%14.57M
Research and development costs -64.78%17.25M-60.47%18.69M-14.49%148.27M-52.97%21.5M-39.71%30.53M18.77%48.97M32.03%47.28M31.34%173.39M22.32%45.71M43.55%50.64M
Operating profit 54.95%-25.46M63.67%-21M16.10%-170.96M54.33%-20.93M40.09%-35.73M-9.18%-56.5M-24.16%-57.8M-20.67%-203.77M4.59%-45.83M-31.40%-59.64M
Net non-operating interest income expense -45.90%1.19M3.48%1.7M1,897.75%8M108.76%1.88M1,428.49%2.29M567.80%2.19M332.01%1.64M62.98%-445K194.75%902K-107.23%-172K
Non-operating interest income -32.59%2.17M2.90%2.7M318.77%12.07M57.07%2.93M366.38%3.3M1,006.19%3.22M14,461.11%2.62M4,335.38%2.88M6,334.48%1.87M4,620.00%708K
Non-operating interest expense -4.10%983K1.93%1M22.39%4.07M8.71%1.05M15.57%1.02M34.87%1.03M35.77%983K162.67%3.33M-1.73%964K797.96%880K
Other net income (expense) -8.71M-499K-8.21M
Special income (charges) -----------8.71M---499K---8.21M----------0--0--0
-Less：Restructuring and merger&acquisition ----------8.71M--499K--8.21M----------0--0--0
Income before tax 55.31%-24.27M65.63%-19.31M15.94%-171.67M56.50%-19.54M30.35%-41.66M-4.00%-54.31M-18.84%-56.16M-20.08%-204.21M8.29%-44.92M-31.54%-59.81M
Income tax
Net income 55.31%-24.27M65.63%-19.31M15.94%-171.67M56.50%-19.54M30.35%-41.66M-4.00%-54.31M-18.84%-56.16M-20.08%-204.21M8.29%-44.92M-31.54%-59.81M
Net income continuous Operations 55.31%-24.27M65.63%-19.31M15.94%-171.67M56.50%-19.54M30.35%-41.66M-4.00%-54.31M-18.84%-56.16M-20.08%-204.21M8.29%-44.92M-31.54%-59.81M
Minority interest income
Net income attributable to the parent company 55.31%-24.27M65.63%-19.31M15.94%-171.67M56.50%-19.54M30.35%-41.66M-4.00%-54.31M-18.84%-56.16M-20.08%-204.21M8.29%-44.92M-31.54%-59.81M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 55.31%-24.27M65.63%-19.31M15.94%-171.67M56.50%-19.54M30.35%-41.66M-4.00%-54.31M-18.84%-56.16M-20.08%-204.21M8.29%-44.92M-31.54%-59.81M
Basic earnings per share 57.45%-0.269.23%-0.1632.11%-1.4863.64%-0.1642.62%-0.3514.55%-0.4711.86%-0.529.54%-2.1835.29%-0.443.17%-0.61
Diluted earnings per share 57.45%-0.269.23%-0.1632.11%-1.4863.64%-0.1642.62%-0.3514.55%-0.4711.86%-0.529.54%-2.1835.29%-0.443.17%-0.61
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ----Unqualified Opinion--------------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data